Urology eLearning Workshop; A guide to NMIBC - Module 3 NMIBC evidence based guidelines

Online Course • medac Pharma

About the CPD course

This is the third module of an eLearning course which features 6 interactive modules; covering a full range of topics within non-muscle invasive bladder cancer. When you finish this module; you should be able to describe the following for this condition; The role of bladder cancer guidelines in clinical practice; Basics of evidence-based guidelines development; Recommendations for NMIBC in the latest UK (NICE) guidelines on bladder cancer; How they compare to European (EAU; European Association of Urology) guidelines on NMIBC.

CPD Provider

medac Pharma

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

medac Pharma

medac Pharma is a privately owned, pharmaceutical company specialising in the development, diagnosis and treatment of diseases within the key areas of oncology, urology, haematology and autoimmune. The company was originally founded in Germany in 1970 and the UK operation was established in 1993. Since then we have become known for developing innovative products from standard cancer chemotherapy to niche speciality medicines.